Rufinamide: a new anti-epileptic medication
Authors:
- 14 August 2007
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 8 (12) , 1931-1940
Abstract
(2007). Rufinamide: a new anti-epileptic medication. Expert Opinion on Pharmacotherapy: Vol. 8, No. 12, pp. 1931-1940. doi: 10.1517/14656566.8.12.1931Keywords
This publication has 14 references indexed in Scilit:
- The Effect of the New Antiepileptic Drug Rufinamide on Cognitive FunctionsEpilepsia, 2006
- Pregabalin Add‐on Treatment in Patients with Partial Seizures: A Novel Evaluation of Flexible‐dose and Fixed‐dose Treatment in a Double‐blind, Placebo‐controlled StudyEpilepsia, 2005
- Efficacy and Safety of Rufinamide Adjunctive Therapy in Patients with Lennox–Gastaut Syndrome (LGS): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel TrialNeurology, 2005
- Glutamate Receptor Antagonists and Benzodiazepine Inhibit the Progression of Granule Cell Dispersion in a Mouse Model of Mesial Temporal Lobe EpilepsyEpilepsia, 2005
- Kindling Limits the Interictal Neuronal Temporal Response Properties in Cat Primary Auditory CortexEpilepsia, 2005
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000
- The influence of food on the disposition of the antiepileptic rufinamide in healthy volunteersBiopharmaceutics & Drug Disposition, 1998
- Intra- and Inter-Subject Variabilities of CGP 33101 after Replicate Single Oral Doses of Two 200-mg Tablets and 400-mg SuspensionPharmaceutical Research, 1995
- PHARMACOKINETICS OF A NEW ANTICONVULSANT(CGP 33101) IN EPILEPTIC MALE PATIENTS AND HEALTHY MALE SUBJECTS AFTER SINGLE ASCENDING ORAL DOSES OF 400–1200 mgAmerican Journal of Therapeutics, 1994
- Seizure recurrence after a 1st unprovoked seizureNeurology, 1990